LISOFYLLINE (LSF) REDUCES INFECTION-RATE AND IMPROVES SURVIVAL IN PTSUNDERGOING ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) - RESULTS OF ARANDOMIZED, PLACEBO-CONTROLLED TRIAL

Authors
LIST A MAZIARZ R STIFF P JANSEN J LIESFELD J SCHUSTER M ANDREWS DF KARANES I WOLF S LITZOW M
Citation
A. List et al., LISOFYLLINE (LSF) REDUCES INFECTION-RATE AND IMPROVES SURVIVAL IN PTSUNDERGOING ALLOGENIC BONE-MARROW TRANSPLANTATION (BMT) - RESULTS OF ARANDOMIZED, PLACEBO-CONTROLLED TRIAL, Blood, 88(10), 1996, pp. 1825-1825
Citations number
NO
Categorie Soggetti
Hematology
Journal title
Blood → ACNP
ISSN journal
00064971
Volume
88
Issue
10
Year of publication
1996
Part
1
Supplement
1
Pages
1825 - 1825
Database
ISI
SICI code
0006-4971(1996)88:10<1825:L(RIAI>2.0.ZU;2-P